# Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission

> **NCT01686334** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Zwi Berneman** · enrollment: 130 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** DC vaccine

## Key facts

- **NCT ID:** NCT01686334
- **Lead sponsor:** Zwi Berneman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-10
- **Primary completion:** 2025-12
- **Final completion:** 2027-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2024-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01686334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01686334, "Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01686334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*